An observational study in Addiction, sponsored by King's College London. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by King's College London · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Alcohol and other drug (AOD) use disorders are associated with a range of adverse outcomes. Relapse following AOD treatment is common. Attendance at Mutual Aid Groups (MAGs) is associated with improved health outcomes and reduced healthcare utilisation costs. National guidance recommends that clinical staff promote MAG attendance, but few patients are referred to, or attend, MAGs. An intensive referral intervention, developed in the United States of America has been shown to increase engagement with MAGs. The aim of this National Institute for Health Research (NIHR)-funded study is to adapt and test a Facilitated Access to Mutual Aid (FAMA) intervention and staff training for delivery in community AOD services in England.
Phase one of this study consists of qualitative focus groups conducted with staff of community AOD services and adults receiving AOD treatment. Eight focus groups will explore participants' views of MAGs and the existing American FAMA intervention. The FAMA intervention will then be adapted and staff training developed, based on the focus group findings and input from patient and public involvement and engagement (PPIE) groups.
Phase two of this study consists of testing the adapted FAMA intervention. Staff in one community AOD service will receive the newly developed FAMA training. They will deliver FAMA to people who are currently receiving AOD treatment service. Each session will be recorded and the fidelity of intervention delivery will be assessed by the research team using a checklist. Staff and patient feedback will be collected using brief questionnaires in informal feedback sessions. The FAMA intervention will be refined and delivered again with another round of feedback being collected. A final version of the FAMA intervention will then be agreed by the research team and PPIE groups.
521 studies on the registry are indexed under Behavior, Addictive; 124 are open to participants now.
This study's planned enrollment of 84 is below the median of 158 across 106 observational studies indexed under Behavior, Addictive.
Browse Behavior, Addictive studies →King's College London is the lead sponsor of 524 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults aged 18+ years who are accessing AOD treatment and staff, aged 18+ years who are working in paid client facing role in an AOD treatment service.
Phase one (staff) inclusion criteria:
Phase one (people accessing AOD treatment) inclusion criteria:
Phase two (staff) inclusion criteria:
Phase two (people accessing AOD treatment) inclusion criteria:
Exclusion Criteria:
Qualitative focus groups
Qualitative focus groups
Time frame: Focus groups will last approximately 90 minutes
Acceptability of Intervention measure (AIM) adapted for FAMA
Measures whether participants find FAMA to be acceptable
Time frame: Maximum 10 weeks from enrolment in the study
Feasibility of Intervention (FIM) adapted for FAMA
Measures whether participants find FAMA to be feasible
Time frame: Maximum 10 weeks from enrolment in the study
Appropriateness Measure (IAM) adapted for FAMA
Measures whether participants find FAMA to be appropriate
Time frame: Maximum 10 weeks from enrolment in the study
No study locations are listed for this record.
Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.